RIL
KMTS

Rothschild Investment LLC’s Kestra Medical Technologies KMTS Stock Holding History

Rothschild Investment LLC’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712 Buy
28
+3
+12% +$63 ﹤0.01% 3174
2026
Q1 		$498 Buy
25
+22
+733% +$519 ﹤0.01% 3127
2025
Q4 		$80 Buy
+3
New +$77 ﹤0.01% 3235

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Rothschild Investment LLC's KMTS Position: Q2 2026 in Review

Rothschild Investment LLC increased its Kestra Medical Technologies (KMTS) stake by 12% in Q2 2026, buying an estimated $63 and bringing the position to 28 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #3174.

Rothschild Investment LLC first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Rothschild Investment LLC held 28 shares of Kestra Medical Technologies worth $712 as of Q2 2026.
  • Rothschild Investment LLC bought 3 Kestra Medical Technologies shares in Q2 2026, an estimated $63.
  • Kestra Medical Technologies made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3174 holding.
  • Rothschild Investment LLC first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.